Bicara Therapeutics Inc. Common Stock (BCAX) Ownership

$10.13

south_east
-$0.27 (-2.6%)
Day's range
$9.79
Day's range
$10.52

Bicara Therapeutics Inc. Common Stock Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 6.96 M $121.17 M   0.00% 12.78%
SIREN, L.L.C. 02/14/2025 3.27 M $57.01 M   6.51% 6.02%
02/14/2025 3.17 M $55.23 M   100.00% 5.83%
TPG GP A, LLC 02/14/2025 3.01 M $52.44 M   0.00% 5.53%
OMEGA FUND MANAGEMENT, LLC 02/14/2025 2.20 M $38.41 M   0.00% 4.05%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/14/2025 2.18 M $37.89 M   171.91% 4.00%
FMR LLC 02/13/2025 2.12 M $36.88 M   -6.89% 3.89%
BRAIDWELL LP 02/14/2025 2.00 M $34.85 M   20.70% 3.68%
DEEP TRACK CAPITAL, LP 02/14/2025 2.00 M $34.84 M   150.99% 3.68%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 02/14/2025 1.80 M $31.27 M   0.00% 3.30%
FAIRMOUNT FUNDS MANAGEMENT LLC 02/14/2025 1.28 M $22.37 M   0.00% 2.36%
BLACKROCK, INC. 02/07/2025 1.26 M $21.98 M   100.00% 2.32%
FIL LTD 02/13/2025 1.01 M $17.66 M   0.00% 1.86%
FORESITE CAPITAL MANAGEMENT VI LLC 02/14/2025 950,000 $16.55 M   100.00% 1.75%
BLACKSTONE INC. 02/14/2025 913,060 $15.91 M   40.47% 1.68%
JANUS HENDERSON GROUP PLC 02/14/2025 863,846 $15.01 M   -27.30% 1.59%
BAKER BROS. ADVISORS LP 02/14/2025 833,333 $14.52 M   0.00% 1.53%
ALLIANCEBERNSTEIN L.P. 02/12/2025 821,264 $14.31 M   16.00% 1.51%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 757,968 $13.20 M   -0.78% 1.39%
VESTAL POINT CAPITAL, LP 02/14/2025 710,000 $12.37 M   67.06% 1.30%
02/14/2025 643,381 $11.21 M   100.00% 1.18%
AISLING CAPITAL MANAGEMENT LP 02/12/2025 568,919 $9.91 M   0.00% 1.05%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 466,642 $8.13 M   859.40% 0.86%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/14/2025 445,975 $7.77 M   0.00% 0.82%
MORGAN STANLEY 02/14/2025 402,918 $7.02 M   20,045.90% 0.74%
MILLENNIUM MANAGEMENT LLC 02/14/2025 385,406 $6.71 M   28.66% 0.71%
FIRST TURN MANAGEMENT, LLC 02/14/2025 346,170 $6.03 M   -38.45% 0.64%
ORBIMED ADVISORS LLC 02/14/2025 298,301 $5.20 M   9.71% 0.55%
WOODLINE PARTNERS LP 02/14/2025 275,692 $4.80 M   -0.82% 0.51%
NORTHERN TRUST CORP 02/14/2025 159,043 $2.77 M   100.00% 0.29%
02/14/2025 135,000 $2.35 M   100.00% 0.25%
DAFNA CAPITAL MANAGEMENT LLC 02/14/2025 105,500 $1.84 M   100.00% 0.19%
TD ASSET MANAGEMENT INC 02/11/2025 102,420 $1.78 M   0.00% 0.19%
NORGES BANK 02/12/2025 70,000 $1.22 M   100.00% 0.13%
MARSHALL WACE, LLP 02/13/2025 67,733 $1.18 M   100.00% 0.12%
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) 02/10/2025 38,035 $646,595   100.00% 0.07%
BANK OF AMERICA CORP /DE/ 02/14/2025 33,677 $586,653   658.32% 0.06%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/14/2025 29,138 $507,584   27.47% 0.05%
XTX TOPCO LTD 02/13/2025 27,334 $476,158   100.00% 0.05%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 25,028 $435,988   100.00% 0.05%
MAVEN SECURITIES LTD 02/14/2025 25,000 $435,500   -50.00% 0.05%
VERITION FUND MANAGEMENT LLC 02/14/2025 21,630 $376,795   100.00% 0.04%
WEXFORD CAPITAL LP 02/14/2025 20,000 $348,400   100.00% 0.04%
CINCTIVE CAPITAL MANAGEMENT LP 02/12/2025 16,984 $295,861   88.69% 0.03%
CITIGROUP INC 02/12/2025 15,488 $269,801   6,046.03% 0.03%
LMR PARTNERS LLP 02/14/2025 15,150 $263,913   100.00% 0.03%
CAXTON CORP 02/14/2025 10,941 $190,593   0.00% 0.02%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 10,907 $190,000   100.00% 0.02%
COREBRIDGE FINANCIAL, INC. 02/11/2025 9,597 $167,180   100.00% 0.02%
FEDERATED HERMES, INC. 02/13/2025 8,000 $139,360   0.00% 0.01%

Bicara Therapeutics Inc. Common Stock institutional Ownership - FAQ's

During the previous two years, 77 institutional investors and hedge funds held shares of Bicara Therapeutics Inc. Common Stock. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 6.96 M

Siren, L.L.C.: 3.27 M

TPG GP A, LLC: 3.01 M

Omega Fund Management, LLC: 2.2 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 2.18 M

FMR LLC: 2.12 M

85.26% of Bicara Therapeutics Inc. Common Stock stock is owned by institutional investors.

Institutional investors have bought a total of 39.09 M shares in the last 24 months. This purchase volume represents approximately $395.96 M in transactions.